Chemsex, PrEP, and HIV Prevention Gaps: Public Health Implications

Persistent Gaps in HIV Prevention Among Chemsex Participants

Recent evidence from a 2026 review (OpenAlex W7225403080) demonstrates that individuals engaging in chemsex—defined as the intentional use of psychoactive substances to enhance sexual experiences—continue to face significant gaps in HIV prevention, despite high levels of awareness and willingness to use pre-exposure prophylaxis (PrEP). Chemsex practices, which often involve polysubstance use, condomless sex, and multiple partners, are associated with elevated risk for HIV and other sexually transmitted infections (STIs). The review introduces the concept of a 'prevention divide': a persistent gap between high HIV/STI risk and ongoing engagement with biomedical prevention methods such as PrEP.

Mechanisms: Structural Barriers Over Motivation

Structural barriers, rather than lack of motivation, are the primary obstacles to sustained PrEP engagement among chemsex participants. The review synthesizes longitudinal and cross-sectional studies from Europe, Asia, North America, and South America, confirming that chemsex is strongly associated with increased risk for bacterial STIs and HIV. However, the gap in prevention is rarely due to unwillingness; both chemsex users and PrEP users engaging in chemsex often express high acceptability and short-term adherence to PrEP. Instead, factors such as cost, poor mental health, fragmented healthcare services, and limited provider training undermine the translation of motivation into durable protection.

One non-obvious insight from the review is that even in settings with high PrEP uptake, discontinuation rates spike when users encounter service interruptions or stigma from healthcare providers. This suggests that interventions focused solely on individual behavior, without addressing systemic barriers, are unlikely to close the prevention divide.

Policy and Research Implications: Beyond MSM-Centric Models

Current public health strategies and research on chemsex and PrEP remain largely centered on men who have sex with men (MSM), leaving significant knowledge gaps regarding other high-risk groups, such as heterosexuals, transgender people, sex workers, and migrants. The review calls for more disaggregated data and tailored interventions to address the needs of these underserved populations.

• Integrated, person-centered care: The authors recommend combining behavioral health, harm reduction, and social support services to address the complex needs of chemsex participants.
• Provider training: Enhanced training for healthcare providers on chemsex, substance use, and sexual health is essential to reduce stigma and improve service delivery.
• Policy reform: Reducing financial barriers and improving service integration are critical for sustained PrEP engagement.

For researchers and program designers, the findings highlight the need to design studies and interventions that consider both psychosocial and structural determinants of health, rather than focusing exclusively on individual risk behaviors.

Risks, Unknowns, and Limitations

While PrEP is highly effective in preventing HIV transmission when taken consistently, the review notes that chemsex participants face unique risks, including increased vulnerability to STIs other than HIV and potential negative mental health outcomes related to substance use. The literature remains limited by its focus on MSM and high-income settings, with less data available for other key populations and low- or middle-income countries.

There is also a risk that fragmented or poorly coordinated services may inadvertently increase disengagement from prevention, especially for individuals facing multiple forms of marginalization. The review underscores that interventions must be context-sensitive and avoid one-size-fits-all approaches.

Looking Forward: Closing the Prevention Divide

Addressing the prevention divide among chemsex participants will require systemic changes in how sexual health, substance use, and mental health services are delivered. Integrated, stigma-free, and person-centered care models offer a promising path forward, but will demand investment in provider training, cross-sector collaboration, and policy reform to reduce cost and access barriers.

For funders, policymakers, and researchers, the key challenge is to move beyond awareness campaigns and individual behavior change models, and instead build structural supports that enable sustained engagement with biomedical prevention. As new data emerges on underserved populations and innovative care models, ongoing evaluation and adaptation will be critical to achieving equitable HIV prevention outcomes.

By Dr. Alex Morgan, MPH, PhD. Reviewed by Dr. Jamie Lin, MD, on 2026-11-10. Sources: OpenAlex W7225403080, primary literature as cited.

How we research: This analysis is based on direct review of the cited 2026 systematic review and supporting primary sources. All clinical and policy statements are referenced to original research or regulatory documentation.